Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma Ltd has filed a routine SEBI compliance certificate confirming that the company did not deviate from the stated purpose for which it raised funds through a preferential issue of warrants. The company had allotted 88,08,000 warrants on 6 August 2025 at Rs. 42.25 each, collecting Rs. 9.30 crore as the 25% subscription amount, with the remaining 75% to be received within 18 months. The entire Rs. 9.30 crore received so far has been deployed towards working capital, which was approved for up to 85% of the total proceeds. The Audit Committee reviewed the statement and had no comments, and the auditors also raised no objections.
This is a routine regulatory filing with no negative implications for shareholders. It confirms that the company is using the funds raised from the warrant issue exactly as disclosed to investors, which is a positive sign of corporate governance. No immediate stock price impact is expected from this disclosure.